Back to top
more

ICU Medical, Inc. (ICUI)

(Real Time Quote from BATS)

$195.73 USD

195.73
16,039

-1.13 (-0.57%)

Updated Aug 3, 2021 10:47 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
2Buy19.14%
3Hold10.74%
4Sell6.46%
5Strong Sell3.16%
S&P50011.27%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (178 out of 253)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Earnings Preview: ICU Medical (ICUI) Q2 Earnings Expected to Decline

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICU Medical (ICUI) Q1 Earnings and Revenues Top Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 5.88% and 4.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 48.44% and 13.53%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: ICU Medical (ICUI) Q3 Earnings Expected to Decline

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session

ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Trina Mukherjee headshot

Medical Products Stock Earnings on Aug 10: CGC, SDGR & More

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Gibraltar Industries, PJT Partners, ICU Medical, eXp World and Innovative Industrial Properties

Zacks.com featured highlights include: Gibraltar Industries, PJT Partners, ICU Medical, eXp World and Innovative Industrial Properties

Shrabana Mukherjee headshot

Buy These 5 Stocks on New Analyst Coverage Amid Coronavirus

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Zacks.com featured highlights include: eXp, American States Water, ICU Medical, Universal Technical Institute and SFL

Zacks.com featured highlights include: eXp, American States Water, ICU Medical, Universal Technical Institute and SFL

Shrabana Mukherjee headshot

New Analyst Coverage Brings 5 Stocks in Focus Amid Coronavirus

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

ResMed (RMD) Grows on SaaS Capabilities Amid Rising Expenses

Within SaaS, ResMed (RMD) registers growing momentum in the Brightree service portfolio.

Steady Global Growth, Product Launches Aid Hill-Rom Business

Hill-Rom (HRC) holds an encouraging 2022 outlook in terms of product launches.

ICU Medical (ICUI) Q4 Earnings and Revenues Beat Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 19.75% and 6.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical (ICUI) Q3 Earnings and Revenues Beat Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 1.85% and 6.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for August 30th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Moving Average Crossover Alert: ICU Medical

ICU Medical, Inc. (ICUI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

ICU Medical (ICUI) Misses Q2 Earnings Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of -4.78% and 1.32%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: ICU Medical (ICUI) Q2 Earnings Expected to Decline

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: ICU Medical (ICUI) Q1 Earnings Expected to Decline

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance

Higher revenues, solid segmental performance and strong adjusted gross margins benefit CONMED's (CNMD) Q1 earnings. However, high long-term debt remains a concern.